Clinical Trials Browser

NCT07524413 2026-04-13

Becotatug Vedotin (MRG003) With PD-1 Blockade and Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma

Phase 3 Not yet recruiting

514 enrolled

Head & Neck

Nasopharyngeal Neoplasms

NCT07441681 2026-04-03

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin

Phase 3 Not yet recruiting

454 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT07509099 2026-04-03

Cetuximab Combined With Pembrolizumab or Finotonlimab and Chemotherapy in R/M HNSCC

Phase 3 Not yet recruiting

316 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT07264075 2026-04-02

ILLUMINE

Phase 3 Not yet recruiting

780 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT07453472 2026-03-06

PDT CALCI HOL

Phase 3 Not yet recruiting

166 enrolled

Head & Neck

Leukoplakia, Oral

NCT07432087 2026-02-25

Camrelizumab Combined With EGFR Monoclonal Antibody or Chemotherapy for Perioperative Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma

Phase 3 Not yet recruiting

246 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT07402538 2026-02-11

Surgery With or Without Neoadjuvant Treatment of SBRT Plus Chemoimmunotherapy in Resectable Locally Advanced Oral and HPV-unrelated Oropharyngeal Squamous Cell Carcinoma

Phase 3 Not yet recruiting

184 enrolled

Head & Neck

Mouth Neoplasms, Oropharyngeal Neoplasms

NCT07385079 2026-02-03

Anlotinib Plus Immunotherapy and Chemoradiotherapy for High-Risk Nasopharyngeal Carcinoma

Phase 3 Not yet recruiting

412 enrolled

Head & Neck

Nasopharyngeal Neoplasms

NCT07371897 2026-01-28

SHINE

Phase 3 Not yet recruiting

154 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT07373990 2026-01-28

Short-course Tislelizumab Combined With Chemoradiotherapy for Nasopharyngeal Carcinoma

Phase 3 Not yet recruiting

418 enrolled

Head & Neck

Nasopharyngeal Neoplasms

NCT07320690 2026-01-06

Neo-Margin

Phase 3 Not yet recruiting

356 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT07238569 2025-11-20

Phase III Trial of EBV-DNA-Guided Adaptive Immunotherapy for Advanced Nasopharyngeal Carcinoma

Phase 3 Not yet recruiting

516 enrolled

Head & Neck

Nasopharyngeal Cancinoma (NPC)

NCT07239674 2025-11-20

DELTA

Phase 3 Not yet recruiting

646 enrolled

Head & Neck

Thyroid Diseases

NCT07072000 2025-07-18

Shrinking the Anterior Border of CTV2 for Nasopharyngeal Carcinoma to Reduce the Radiation of Nasal Cavity

Phase 3 Not yet recruiting

550 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT06957938 2025-05-08

Comparing Neoadjuvant Chemotherapy Combined With PD-1 Inhibitor Versus Neoadjuvant Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Carcinoma

Phase 3 Not yet recruiting

168 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms

NCT06900218 2025-04-02

PD-1 Antibody Sintilimab Combined With Capecitabine as Adjuvant Therapy for High-Risk Nasopharyngeal Carcinoma

Phase 3 Not yet recruiting

664 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT06775756 2025-01-15

Reducing Dose and Irradiated Volume in Cervical Prophylactic Irradiation for Nasopharyngeal Cancer

Phase 3 Not yet recruiting

474 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT06647563 2024-10-18

Neoadjuvant Toripalimab + Chemotherapy ± Cetuximab in Locally Advanced Head and Neck Squamous Cell Carcinoma (Neo-ICT)

Phase 3 Not yet recruiting

355 enrolled

Head & Neck

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck

NCT06486220 2024-07-03

PFLL Combined With PD-1 Antibody With or Without FMT for Oligometastatic NPC,a Phase III ,Open, Randomized Clinical Trial.

Phase 3 Not yet recruiting

96 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT06095167 2023-10-23

Induction Chemotherapy and Immunotherapy Combined Radiotherapy With or Without Concurrent Chemotherapy for Stage III-IVa NPC

Phase 3 Not yet recruiting

476 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT05780294 2023-03-22

A Multi-center, Randomized, Double-blind, Phase III Clinical Trial of Leucogen Versus Placebo on Leukocyte and Platelet Whole-course Management Assisted by PFLL Chemotherapy in the Treatment of Stage IV, Recurrent or Metastatic NPC

Phase 3 Not yet recruiting

132 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT05717764 2023-02-08

Clinical Study of Mitoxantrone Hydrochloride Liposome Injection Combined With Capecitabine Versus Capecitabine Monotherapy in Patients With Recurrent Metastatic Nasopharyngeal Carcinoma Who Failed Platinum-containing Treatment

Phase 3 Not yet recruiting

500 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT05468554 2022-10-19

METHYR

Phase 3 Not yet recruiting

160 enrolled

Head & Neck

Thyroid Neoplasms

NCT04215510 2021-02-23

Early Recurrent Nasopharyngeal Cancer: the Effect of Surgery vs IMRT

Phase 3 Not yet recruiting

286 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT03529279 2018-05-18

CNG Staging Compared With 8th UICC of NPC for Treatment Decision-marking and Selection of Chemotherapy and Radiotherapy

Phase 3 Not yet recruiting

1,324 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT03503136 2018-05-11

NX-NPC

Phase 3 Not yet recruiting

632 enrolled

Head & Neck

Nasopharyngeal Carcinoma